Delivery Order SPE2DB22D2211-SPE2DB25FSCLG
- Not listed
- The Defense Logistics Agency awarded a $2,019.96 delivery order to AmerisourceBergen Drug Corp for Climara Pro Patch 4S, a transdermal hormone delivery system used in medical treatment. The contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed-price transaction with no set-aside designation. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order operates as a child...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,629.53 firm-fixed-price contract is for the supply of CLIMARA PRO PATCH 4S, a transdermal estrogen medication, with a period of performance through March 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a broad range of pharmaceutical products...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,108.88, is for the delivery of CLIMARA PRO PATCH 4S, a hormone replacement therapy medication. The contract is a firm fixed-price arrangement with an ultimate completion date of July 8, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The $3,741.84 contract is for the supply of CLIMARA PRO PATCH 4S, a topical estrogen therapy. Amerisourcebergen Drug Corp is the prime contractor and will provide the medication to DLA Troop Support Medical facilities in support of military treatment programs. The order is part of a...
- AmerisourceBergen Drug Corp was awarded a $1,009.98 delivery order for Climara Pro Patch 4S by the Defense Logistics Agency (DLA) on August 5, 2025, with an ultimate completion date of August 6, 2025. This firm fixed-price, competitively awarded contract is being performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader pharmaceutical supply relationships with the federal government and...
- The Defense Logistics Agency awarded a $3,789.16 firm fixed price delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for Climara Pro Patch 4S pharmaceutical products. This non-set-aside competitive award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be fulfilled from AmerisourceBergen's corporate office location in...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,382.46 firm fixed price contract is for the supply of CLIMARA PRO PATCH 4S, a hormonal medication. The contract has an ultimate completion date of August 23, 2024. Amerisourcebergen is a large, for-profit pharmaceutical company that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide CLIMARA PRO PATCH 4S, a pharmaceutical product, with a ceiling value of $1,628.83 and a performance period ending on March 21, 2024. This delivery order contract is issued under an indefinite delivery contract (IDC) held by AmerisourceBergen Drug Corp with a potential value of $999,999,999.00 and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of CLIMARA PRO PATCH 4S, a transdermal estrogen-progestin medication. The contract has a ceiling value of $2,273.91 and a completion date of May 3, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide CLIMARA PRO PATCH 4S pharmaceutical products. The potential value of this delivery order is $1,122.88 with a completion date of February 16, 2024. Amerisourcebergen Drug Corp is the prime contractor and there is no set-aside designation mentioned. This delivery order is issued under a larger indefinite delivery contract...
- SPE2DB22D2211Indefinite Delivery Contract
- SPE2DB22D2211-SPE2DB25FSCLGDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,028.18 to AmerisourceBergen Drug Corp for CLIMARA PRO PATCH 4S, a transdermal estradiol patch used for hormone replacement therapy. This firm fixed price delivery order, issued on August 7, 2025, with an ultimate completion date of August 8, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The contract involves no set-aside designation, indicating it was competitively awarded. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's comprehensive $999.99 billion indefinite delivery vehicle with DLA Troop Support Medical (SPE2DX) extending through December 2026, which serves as a global pharmaceutical support mechanism for military healthcare programs. As a major pharmaceutical distributor, AmerisourceBergen regularly supplies the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems with brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's consistent receipt of competitively awarded delivery orders demonstrates its capability to meet federal procurement requirements for critical medical supplies supporting military personnel and veterans.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 8/7/25 |